[HTML][HTML] The gut microbiota (microbiome) in cardiovascular disease and its therapeutic regulation

MM Rahman, F Islam, MH -Or-Rashid… - Frontiers in cellular …, 2022 - frontiersin.org
In the last two decades, considerable interest has been shown in understanding the
development of the gut microbiota and its internal and external effects on the intestine, as …

Deep learning in ophthalmology: the technical and clinical considerations

DSW Ting, L Peng, AV Varadarajan, PA Keane… - Progress in retinal and …, 2019 - Elsevier
The advent of computer graphic processing units, improvement in mathematical models and
availability of big data has allowed artificial intelligence (AI) using machine learning (ML) …

Editor's choice–European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms

A Wanhainen, F Verzini, I Van Herzeele… - European Journal of …, 2019 - ejves.com
Members of this Guideline Writing Committee (GWC) were selected by the European Society
for Vascular Surgery (ESVS) to represent physicians involved in the management of patients …

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP …

K Kotseva, G De Backer… - European journal of …, 2019 - journals.sagepub.com
Aims The aim of this study was to determine whether the Joint European Societies
guidelines on secondary cardiovascular prevention are followed in everyday practice …

[PDF][PDF] 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

V Aboyans, JB Ricco, ML Bartelink… - Kardiologia Polska …, 2017 - journals.viamedica.pl
W 2011 roku ESC opublikowało pierwsze wytyczne dotyczące rozpoznawania i leczenia
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …

[HTML][HTML] Editor's Choice–2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular …

V Aboyans, JB Ricco, MLEL Bartelink, M Björck… - European Journal of …, 2018 - ejves.com
Document Reviewers b, Petr Widimsky, Philippe Kolh, Stefan Agewall, Héctor Bueno,
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …

[PDF][PDF] 2016 European Guidelines on cardiovascular disease prevention in clinical practice

MF Piepoli, AW Hoes, S Agewall… - Polish Heart …, 2016 - journals.viamedica.pl
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …

Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries

G De Backer, P Jankowski, K Kotseva, E Mirrakhimov… - Atherosclerosis, 2019 - Elsevier
Background and aims One of the objectives of the ESC-EORP EUROASPIRE V survey is to
determine how well European guidelines on the management of dyslipidaemias are …

Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology

BG Nordestgaard - Circulation research, 2016 - Am Heart Assoc
Scientific interest in triglyceride-rich lipoproteins has fluctuated over the past many years,
ranging from beliefs that these lipoproteins cause atherosclerotic cardiovascular disease …

[HTML][HTML] Nutrition and cardiovascular health

R Casas, S Castro-Barquero, R Estruch… - International journal of …, 2018 - mdpi.com
Cardiovascular disease (CVD) is the leading cause of death in Western countries,
representing almost 30% of all deaths worldwide. Evidence shows the effectiveness of …